I agree that this site is using cookies. You can find further informations here.
X
Moris, Philippe
103  results:
Search for persons X
?
1

Safety and Immunogenicity of a ChAd155-Vectored Respiratory..:

Díez-Domingo, Javier ; Sáez-Llorens, Xavier ; Rodriguez-Weber, Miguel A...
The Journal of Infectious Diseases.  227 (2022)  11 - p. 1293-1302 , 2022
Link: https://doi.org/10.1093/..
 
?
2

Randomized, Double-Blind, Reference-Controlled, Phase 2a St..:

Leroux-Roels, Isabel ; Waerlop, Gwenn ; Tourneur, Jessika...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

Characterization of B-cell and T-cell responses to a tetrav..:

Friberg, Heather ; Gargulak, Morgan ; Kong, Amanda...
npj Vaccines.  7 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
4

Whole blood can be used as an alternative to isolated perip..:

Moris, Philippe ; Bellanger, Aurélie ; Ofori-Anyinam, Opokua...
Journal of Immunological Methods.  492 (2021)  - p. 112940 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Long-term Cross-reactivity Against Nonvaccine Human Papillo..:

Folschweiller, Nicolas ; Behre, Ulrich ; Dionne, Marc...
The Journal of Infectious Diseases.  219 (2019)  11 - p. 1799-1803 , 2019
Link: https://doi.org/10.1093/..
 
?
6

First-in-Human Randomized Study to Assess the Safety and Im..:

Snape, Matthew D ; Dieussaert, Ilse ; Gonzalez-Lopez, Antonio...
Clinical Infectious Diseases.  70 (2019)  10 - p. 2073-2081 , 2019
Link: https://doi.org/10.1093/..
 
?
7

Non-typeable Haemophilus influenzae protein vaccine in adul..:

Wilkinson, Tom M.A. ; Schembri, Stuart ; Brightling, Christopher...
Vaccine.  37 (2019)  41 - p. 6102-6111 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Cell-mediated immune responses to different formulations of..:

Moris, Philippe ; Bauer, Kristen M. ; Currier, Jeffrey R....
Human Vaccines & Immunotherapeutics.  15 (2019)  9 - p. 2090-2105 , 2019
Link: https://doi.org/10.1080/..
 
?
9

Safety and immunogenicity of the M72/AS01 E candidate tuber..:

Gillard, Paul ; Yang, Pan-Chyr ; Danilovits, Manfred...
Tuberculosis.  100 (2016)  - p. 118-127 , 2016
Link: https://doi.org/10.1016/..
 
?
10

Impact of adjuvants on CD4+ T cell and B cell responses to ..:

Leroux-Roels, Geert ; Marchant, Arnaud ; Levy, Jack...
Clinical Immunology.  169 (2016)  - p. 16-27 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Adjuvant system AS02V enhances humoral and cellular immune ..:

Leroux-Roels, Isabel ; Devaster, Jeanne-Marie ; Leroux-Roels, Geert...
Vaccine.  33 (2015)  4 - p. 577-584 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Ef..:

Ockenhouse, Christian F. ; Regules, Jason ; Tosh, Donna...
PLOS ONE.  10 (2015)  7 - p. e0131571 , 2015
Link: https://doi.org/10.1371/..
 
?
13

Immunogenicity of heterologous H5N1 influenza booster vacci..:

Langley, Joanne M. ; Frenette, Louise ; Jeanfreau, Robert...
Vaccine.  33 (2015)  4 - p. 559-567 , 2015
Link: https://doi.org/10.1016/..
 
?
14

Phase II, randomized, open, controlled study of AS03‐adjuva..:

Díez‐Domingo, Javier ; Baldó, José‐María ; Planelles‐Catarino, Maria Victoria...
Influenza and Other Respiratory Viruses.  9 (2015)  2 - p. 68-77 , 2015
Link: https://doi.org/10.1111/..
 
?
15

Safety and immunogenicity of candidate vaccine M72/AS01E in..:

Penn-Nicholson, Adam ; Geldenhuys, Hennie ; Burny, Wivine...
Vaccine.  33 (2015)  32 - p. 4025-4034 , 2015
Link: https://doi.org/10.1016/..
 
1-15